Zobrazeno 1 - 10
of 29
pro vyhledávání: '"Naofumi Shiota"'
Autor:
Daniel P. Lewis, BMed, MTrauma, Seth M. Tarrant, B Biomed Sc (Hons), MB BS, FRACS, FAOrthA, Stuart MacKenzie, BMed, BMedSc(Hons), FRACS, FAOrthA, Lachlan Cornford, MBBS(Hons), FRACS, FAOrthA, Toru Sato, MD, Naofumi Shiota, MD, Zsolt J. Balogh, MD, PhD, FRACS, FACS
Publikováno v:
OTA International, Vol 6, Iss 1S (2023)
Summary:. Knee arthroplasty, both total knee and unicompartmental, has had a significant impact on millions of patients globally. Although satisfaction is usually high, complications such as periprosthetic fracture are increasingly common. Distal fem
Externí odkaz:
https://doaj.org/article/d8a4240d33ab4a02b65ec6b74d94f306
Autor:
Lorenz C Hofbauer, ProfMD, Richard Witvrouw, MD, Zsuzsanna Varga, MD, Naofumi Shiota, MD, Malika Cremer, PharmD, Laszlo B Tanko, MD, Daniel Rooks, PhD, Lixin Zhang Auberson, MD, Michal Arkuszewski, MD, Nathalie Fretault, MSc, Agnes Annette Schubert-Tennigkeit, MD, Dimitris A Papanicolaou, MD, Chris Recknor, MD
Publikováno v:
The Lancet. Healthy Longevity, Vol 2, Iss 5, Pp e263-e274 (2021)
Summary: Background: Older adult patients (ie, those aged ≥60 years) undergoing surgery for hip fracture repair frequently experience loss of muscle mass and strength due to poor mobility and delayed functional recovery. No proven treatment is curr
Externí odkaz:
https://doaj.org/article/3cead3b30953497886dc0746cff88602
Autor:
Yasuhisa Izushi, Yoichiro Takami, Soichiro Ushio, Tomonori Tetsunaga, Naofumi Shiota, Hiroshi Yamamoto, Toru Sato, Yoshihisa Kitamura
Publikováno v:
Medicine. 101(47)
Edoxaban (Edx) has been approved to prevent venous thromboembolism after total knee and/or hip arthroplasty in Japan. However, the risk of anemia with Edx treatment remains elusive. No risk factors for Edx-associated anemia after orthopedic surgery h
Autor:
Yasuaki Yamakawa, Takenori Uehara, Kenji Shigemoto, Shimpei Kitada, Atsuhiko Mogami, Naofumi Shiota, Takeshi Doi, Masahide Yoshimura, Tomoyuki Noda, Takeshi Sawaguchi
Publikováno v:
SSRN Electronic Journal.
Autor:
Hiroshi Furukawa, Shomi Oka, Naoki Kondo, Yasuaki Nakagawa, Naofumi Shiota, Kenji Kumagai, Keiji Ando, Tsutao Takeshita, Takenori Oda, Yoshinori Takahashi, Kazutaka Izawa, Yoichi Iwasaki, Kazuhiro Hasegawa, Hiroshi Arino, Takeshi Minamizaki, Norie Yoshikawa, Shinjiro Takata, Yasuo Yoshihara, Shigeto Tohma
Publikováno v:
The Journal of clinical endocrinology and metabolism. 107(5)
Context Atypical femoral fractures (AFFs) are very rare atraumatic or mild trauma fractures in the subtrochanteric region or femoral shaft. Some unique genetic variants in Asian populations might confer susceptibility to AFF, since the incidence of A
Autor:
Lorenz C Hofbauer, Agnes Annette Schubert-Tennigkeit, Michal Arkuszewski, Richard Witvrouw, Nathalie Fretault, Chris Recknor, Malika Cremer, Daniel Rooks, Lixin Zhang Auberson, Zsuzsanna Varga, Dimitris Papanicolaou, Laszlo B Tanko, Naofumi Shiota
Publikováno v:
The Lancet. Healthy Longevity, Vol 2, Iss 5, Pp e263-e274 (2021)
Summary: Background: Older adult patients (ie, those aged ≥60 years) undergoing surgery for hip fracture repair frequently experience loss of muscle mass and strength due to poor mobility and delayed functional recovery. No proven treatment is curr
Publikováno v:
The Proceedings of Mechanical Engineering Congress, Japan. 2022:J026-01
Autor:
Hiroshi Furukawa, Shomi Oka, Naoki Kondo, Yasuaki Nakagawa, Naofumi Shiota, Kenji Kumagai, Keiji Ando, Tsutao Takeshita, Takenori Oda, Yoshinori Takahashi, Kazutaka Izawa, Yoichi Iwasaki, Kazuhiro Hasegawa, Hiroshi Arino, Takeshi Minamizaki, Norie Yoshikawa, Shinjiro Takata, Yasuo Yoshihara, Shigeto Tohma
Publikováno v:
Journal of Clinical Endocrinology & Metabolism; May2022, Vol. 107 Issue 5, pe1890-e1898, 9p
Autor:
Tomonori Tetsunaga, Yasuhisa Izushi, Ritsugi Takuma, Yoichiro Takami, Yusuke Ookura, Toru Sato, Takashi Egawa, Naofumi Shiota, Kenichi Shimada, Tsukasa Kiuchi
Publikováno v:
Biological & Pharmaceutical Bulletin. 39:516-523
Edoxaban, an oral direct factor Xa inhibitor, was developed and approved for anticoagulant thromboprophylaxis after total knee arthroplasty (TKA). We retrospectively investigated the postoperative anemia by oral administration of edoxaban 30 mg compa
Publikováno v:
The Proceedings of Mechanical Engineering Congress, Japan. 2020:J02116